Format

Send to

Choose Destination
PLoS One. 2014 Sep 25;9(9):e108051. doi: 10.1371/journal.pone.0108051. eCollection 2014.

RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.

Author information

1
Department of Pediatrics, Children's Research Institute, and Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
2
Cellular Dynamics International Inc., Madison, Wisconsin, United States of America.
3
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

Abstract

Cardiac hypertrophy is an independent risk factor for cardiovascular disease and heart failure. There is increasing evidence that microRNAs (miRNAs) play an important role in the regulation of messenger RNA (mRNA) and the pathogenesis of various cardiovascular diseases. However, the ability to comprehensively study cardiac hypertrophy on a gene regulatory level is impacted by the limited availability of human cardiomyocytes. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer the opportunity for disease modeling. Here we utilize a previously established in vitro model of cardiac hypertrophy to interrogate the regulatory mechanism associated with the cardiac disease process. We perform miRNA sequencing and mRNA expression analysis on endothelin 1 (ET-1) stimulated hiPSC-CMs to describe associated RNA expression profiles. MicroRNA sequencing revealed over 250 known and 34 predicted novel miRNAs to be differentially expressed between ET-1 stimulated and unstimulated control hiPSC-CMs. Messenger RNA expression analysis identified 731 probe sets with significant differential expression. Computational target prediction on significant differentially expressed miRNAs and mRNAs identified nearly 2000 target pairs. A principal component analysis approach comparing the in vitro data with human myocardial biopsies detected overlapping expression changes between the in vitro samples and myocardial biopsies with Left Ventricular Hypertrophy. These results provide further insights into the complex RNA regulatory mechanism associated with cardiac hypertrophy.

PMID:
25255322
PMCID:
PMC4177883
DOI:
10.1371/journal.pone.0108051
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center